{"entity":{"type":"insider","cik":"0001781117","url":"/insider/0001781117","json_url":"/insider/0001781117.json","name":"MacDonald Kelly","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":8,"first":"2019-11-12","last":"2020-12-08","span_basis":"filed_date"},"name_variants":[{"name":"MacDonald Kelly","source":"filing","n_filings":8,"first_seen":"2019-11-12","last_seen":"2020-12-08"}],"transactions":[{"id":2120449,"accession":"0001209191-20-062229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-062229","line_url":"/filing/0001209191-20-062229#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5639.0,"shares_display":"5,639","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":70487.5,"total_display":"70,487.50","total_whole":"70,488","shares_owned_after":93041.0,"shares_owned_after_display":"93,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-08","scope":"insider"},{"id":3019124,"accession":"0001209191-20-058270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-058270","line_url":"/filing/0001209191-20-058270#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3561.0,"shares_display":"3,561","price_per_share":11.75,"price_display":"11.75","price_state":"stated","total_value":41841.75,"total_display":"41,841.75","total_whole":"41,842","shares_owned_after":93041.0,"shares_owned_after_display":"93,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-13","scope":"insider"},{"id":3324776,"accession":"0001209191-20-057611","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-057611","line_url":"/filing/0001209191-20-057611","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":925.0,"shares_display":"925","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":10101.0,"total_display":"10,101.00","total_whole":"10,101","shares_owned_after":93141.0,"shares_owned_after_display":"93,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider","n_lines":2},{"id":3324767,"accession":"0001209191-20-057611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-057611","line_url":"/filing/0001209191-20-057611#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1872.0,"shares_display":"1,872","price_per_share":11.25,"price_display":"11.25","price_state":"stated","total_value":21060.0,"total_display":"21,060.00","total_whole":"21,060","shares_owned_after":93966.0,"shares_owned_after_display":"93,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-06","filed_date":"2020-11-10","scope":"insider"},{"id":2689970,"accession":"0001209191-20-054621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-054621","line_url":"/filing/0001209191-20-054621#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22714.0,"shares_display":"22,714","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":238497.0,"total_display":"238,497.00","total_whole":"238,497","shares_owned_after":95838.0,"shares_owned_after_display":"95,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-13","scope":"insider"},{"id":2381678,"accession":"0001209191-20-047469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047469","line_url":"/filing/0001209191-20-047469#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":575.0,"shares_display":"575","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":5830.5,"total_display":"5,830.50","total_whole":"5,831","shares_owned_after":118552.0,"shares_owned_after_display":"118,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-19","scope":"insider"},{"id":2782295,"accession":"0001209191-20-028899","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-028899","line_url":"/filing/0001209191-20-028899","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1153.0,"shares_display":"1,153","price_per_share":10.35,"price_display":"10.35","price_state":"stated","total_value":11933.55,"total_display":"11,933.55","total_whole":"11,934","shares_owned_after":118147.0,"shares_owned_after_display":"118,147","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider","n_lines":2},{"id":2284387,"accession":"0001209191-20-012484","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-012484","line_url":"/filing/0001209191-20-012484","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":11.63,"price_display":"11.63","price_state":"stated","total_value":45357.0,"total_display":"45,357.00","total_whole":"45,357","shares_owned_after":83127.0,"shares_owned_after_display":"83,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-21","filed_date":"2020-02-25","scope":"insider","n_lines":6},{"id":7980741,"accession":"0001209191-19-056191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-056191","line_url":"/filing/0001209191-19-056191","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001781117","owner_name":"MacDonald Kelly","owner_display_name":"MacDonald Kelly","owner_url":"/insider/0001781117","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":987.0,"shares_display":"987","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":10857.0,"total_display":"10,857.00","total_whole":"10,857","shares_owned_after":78444.0,"shares_owned_after_display":"78,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-12","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (Chief Accounting Officer)","n_filings":8,"first_seen":"2019-11-12","last_seen":"2020-12-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001781117","retrieved_at":"2026-08-24T00:12:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}